Analyst Price Target is $1.35
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Ortho Regenerative Technologies in the last 3 months. The average price target is $1.35, with a high forecast of $1.35 and a low forecast of $1.35. The average price target represents a ∞ upside from the last price of $0.00.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Ortho Regenerative Technologies.
Ortho Regenerative Technologies Inc., an orthopedic and sports medicine technology company, engages in researching and developing novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a freeze-dried formulation for the treatment of rotator cuff tears; and Ortho-M, a freeze-dried formulation for the treatment of meniscus tears that are under the large animal studies. It also develops Ortho-C, a freeze-dried matrix for the treatment of articular cartilage; and Ortho-V, a freeze-dried biopolymer for the prevention of osteoarthritis pain that are under the feasibility studies. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.